CHU Saint Pierre — Clinical Trial Site

63 Registered trials

19 Currently recruiting

Organisation

CHU Saint Pierre

Location

Brussels, Belgium

Identifier

ORG-100028265

Address

Waterloolaan 129, 1000, Belgium

Departments

032012: Oncology
056013:Medical oncology
Anesthesiology
BE10006: Hépato-gastro-entérologie
Cardiology
Department of Infectious Disease
Department of Infectious Diseases
Department of Intensive Care
Department of Internal Medicine
Department of Pediatrics
Dermatology
Emergency Department
Gastro-enterologie
Gastro-enterology
Gastroenterology
Gynécologie-Obstétrique
Hematology
Hépato-Gastro-Entérologie
Hepato-Gastroenterology
Infectious diseases
Infectious Diseases Department
La clinique du sein
N/A
Oncology
Oncology Department
Pediatrics
Pneumologie
Pneumology
Pulmonology
Pumonology/ Sleep lab
Rheumatology

Clinical trials at this site (63)

Search interface

A study on the reactogenicity, safety, immune response, and efficacy of a targeted immunotherapy against HSV in healthy participants aged 18… Ended

2024-510571-37-00 Herpes Simplex 7 2023-12-06
Maternal determinants of infant immunity to pertussis (MADI-02) Ended

2024-517893-73-00 Whooping cough 6 2023-09-09
ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended

2022-500535-36-01 Moderately to severely active ulcerative colitis 5 2023-06-12
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
Study of Nemvaleukin Alfa in Combination with Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients with Platinum-Resistant Ep… Ended

2024-513230-38-00 Platinum-Resistant Epithelial Ovarian, Fallopian Tube, 5 2022-12-15
A study to test the safety of MK-1654 and how well MK-1654 works in healthy infants Ended

2022-500350-42-01 Prevention of RSV 10 2022-11-07
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
A study to evaluate the effects of ALIS based treatment in patients newly diagnosed with nontuberculous mycobacterial lung infection caused … Ended

2023-505273-33-00 "Adult Subjects with Newly Diagnosed Nontuberculous Myc 5 2021-02-15
Long-term Study of Apremilast (CC-10004) in Pediatric Subjects from 6 Through 17 Years of Age with Moderate to Severe Plaque Psoriasis Ended

2023-503600-83-00 Moderate to Severe Plaque Psoriasis 5 2020-05-27
The Late Presenter Treatment Optimisation Study (LAPTOP) Ended

2023-505167-36-00 Patients who present late on during their acquisition o 5 2019-08-05
RCT part: COBRA-Slim with or without fast access to TNF blockade for remission induction in early RA. LTE part: Long Term observational fol… Ended

2023-510189-28-00 Rheumatoid Arthritis 6 2018-05-15
Predictive factors and magnitude of response to omalizumab and mepolizumab in allergic and eosinophilic severe asthma: PREDICTUMAB, an open-… Ended

2024-516783-29-00 Severe allergic and eosinophilic asthma 6 2018-04-16
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovar… Ended

2023-508010-42-00 Homologous recombination deficiency advanced ovarian ca 5 2016-09-14
Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Ended

2024-515487-31-00 HIV-infected 6